255 related articles for article (PubMed ID: 23489679)
1. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.
Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA
Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679
[TBL] [Abstract][Full Text] [Related]
2. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
3. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors.
Joselevitch JA; Barra CN; Vargas THM; Pulz LH; Nishiya AT; Kleeb SR; Xavier JG; Catão-Dias JL; Strefezzi RF
Vet Pathol; 2018 Nov; 55(6):849-852. PubMed ID: 30025495
[TBL] [Abstract][Full Text] [Related]
4. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
Berlato D; Murphy S; Laberke S; Rasotto R
Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
[TBL] [Abstract][Full Text] [Related]
5. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
[TBL] [Abstract][Full Text] [Related]
6. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours.
Maglennon GA; Murphy S; Adams V; Miller J; Smith K; Blunden A; Scase TJ
Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685
[TBL] [Abstract][Full Text] [Related]
7. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases.
O'Connell K; Thomson M
Vet Comp Oncol; 2013 Mar; 11(1):51-62. PubMed ID: 22235766
[TBL] [Abstract][Full Text] [Related]
9. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
Giuliano A; Dos Santos Horta R; Constantino-Casas F; Hoather T; Dobson J
J Comp Pathol; 2017 Jan; 156(1):14-20. PubMed ID: 27889201
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression.
Sakai H; Noda A; Shirai N; Iidaka T; Yanai T; Masegi T; Shirai N; Iidaka T; Yanai T; Masegi T
J Comp Pathol; 2002 Nov; 127(4):233-8. PubMed ID: 12443730
[TBL] [Abstract][Full Text] [Related]
12. Comparison between Ki-67 index and mitotic index for predicting outcome in canine mast cell tumours.
van Lelyveld S; Warland J; Miller R; Maw H; Foale R; Goodfellow M; Dobson J
J Small Anim Pract; 2015 May; 56(5):312-9. PubMed ID: 25728289
[TBL] [Abstract][Full Text] [Related]
13. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
Taylor F; Murphy S; Hoather T; Dobson J; Scase T
Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
[TBL] [Abstract][Full Text] [Related]
14. Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling.
Pulz LH; Barra CN; Alexandre PA; Huete GC; Cadrobbi KG; Nishiya AT; de Freitas SH; Fukumasu H; Strefezzi RF
PLoS One; 2019; 14(6):e0217343. PubMed ID: 31216299
[TBL] [Abstract][Full Text] [Related]
15. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
16. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
[TBL] [Abstract][Full Text] [Related]
17. Canine subcutaneous mast cell tumor: characterization and prognostic indices.
Thompson JJ; Pearl DL; Yager JA; Best SJ; Coomber BL; Foster RA
Vet Pathol; 2011 Jan; 48(1):156-68. PubMed ID: 21078881
[TBL] [Abstract][Full Text] [Related]
18. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
20. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
